Tsukuba, Japan

Ryota Hori

This inventor holds 1 USPTO granted patent. Top assignee: Hisamitsu Pharmaceutical Company, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryota Hori. Retrieved from https://idiyas.com/inventor/ryota-hori-9s9bueuv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ryota Hori: Innovator in Microneedle Technology

Introduction

Ryota Hori is a prominent inventor based in Tsukuba, Japan. He is known for his innovative contributions to the field of microneedle technology. His work focuses on enhancing the delivery of biologically active substances through microneedles.

Latest Patents

Ryota Hori holds 1 patent for his invention titled "Microneedle device and method for producing the same." This patent aims to manufacture a microneedle device capable of carrying and administering a larger amount of biologically active substance per microneedle. The method involves coating microneedles with a liquid that contains both a biologically active substance and a sulfated polysaccharide. The resulting microneedle device consists of a substrate, microneedles, and a specialized coating that enhances its functionality.

Career Highlights

Ryota Hori is associated with Hisamitsu Pharmaceutical Company, Inc., where he continues to develop innovative solutions in the pharmaceutical field. His work has significantly contributed to advancements in drug delivery systems.

Collaborations

Ryota Hori collaborates with Shinpei Nishimura, a fellow innovator in the field. Their partnership aims to further enhance the capabilities of microneedle technology.

Conclusion

Ryota Hori's contributions to microneedle technology exemplify the potential of innovative solutions in the pharmaceutical industry. His work not only advances drug delivery methods but also opens new avenues for research and development in this critical area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…